https://doi.org/10.4081/itjm.q.2023.3
La progressione della malattia renale cronica
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
La progressione della malattia renale cronica
G. Pinna
Basso peso alla nascita, numero di nefroni e malattia renale cronica
D. Manfellotto, M. Cortinovis, N. Perico, G. Remuzzi
Malattia renale in corso di diabete mellito: vecchi e nuovi paradigmi
E. Gatti, I. Pellicelli, A. Bovino, D. Fasano, E. Gnappi, L. Zerbini, A. Magnano, S. Pioli, L. Bianchi, A. Caiazza, T.M. Attardo, M. Meschi
Il ruolo dell’ipertensione arteriosa nella malattia renale cronica: vittima e colpevole
A. De Pascalis, D. Vetrano, A. Tomassetti, S. Bianchi, G. Cianciolo
Il ruolo dell’autoimmunità nelle malattie renali
M. Giliberti, V. Di Leo, E.D. Stea, A. Mitrotti, L. Gesualdo
Transizione dal danno renale acuto alla malattia renale cronica
F. Di Mario, M.C. Pacchiarini, E. Fiaccadori
Le frontiere del trattamento dell’iperpotassiemia
A. Montagnani, M. Caselli, S. Cappelli
Downloads
PlumX Metrics
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.